Transgenic Animal Models Of Human Immune Defects
人类免疫缺陷的转基因动物模型
基本信息
- 批准号:10274156
- 负责人:
- 金额:$ 158.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AneurysmAnimalsAreaB-LymphocytesBiochemicalBone MarrowBone Marrow TransplantationCardiovascular systemCellsChronic Granulomatous DiseaseClinicalCystDefectDentalDiagnosisDiseaseDistantEndothelial CellsEnzymesExtramural ActivitiesFunctional disorderGenerationsGenesGeneticGenotypeGenus staphylococcusGoalsHematopoieticHistopathologyHumanHypersensitivityIgEImmuneImpaired wound healingImpairmentIn VitroInfectionInflammationInflammatory Bowel DiseasesInnate Immune ResponseInterleukin-17IntestinesInvestigationJob&aposs SyndromeLaboratoriesLeadLinkLungLung infectionsLymphopeniaMalignant NeoplasmsMicrobiologyMolecularMolecular GeneticsMusMuscle CellsMutationMycosesMyelogenousNADPH OxidaseNational Heart, Lung, and Blood InstituteNational Institute of Allergy and Infectious DiseaseNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNatural ImmunityNewly DiagnosedOccupationsOperative Surgical ProceduresOrganismOsteopeniaPathogenicityPatientsPhagocytesPhenotypePortugalPredispositionProductionRecurrenceReportingResearch PersonnelResistanceRespiratory Tract InfectionsRoleSTAT1 geneSTAT3 geneSpecimenSuperoxidesSyndromeT-LymphocyteTNF geneTransgenic AnimalsTransplant-Related DisorderVascular Endothelial CellWorkarterial tortuositychemokinecohortcongenital immunodeficiencycytokinegain of functiongastrointestinalhuman modelimmune functionimmunopathologyintercellular communicationinterestloss of functionmicrobiome researchmouse modelprogramsrac2 GTP-binding proteinrecurrent infection
项目摘要
We seek to understand the role of phagocytes in immune function through examination of the consequences of immune defects. Our major focus is on chronic granulomatous disease (CGD), which is caused by defects in the enzyme NADPH oxidase. The NADPH oxidase is involved in the generation and control of inflammation, protection from infection, and cell-cell signaling. We have a comprehensive portfolio involving patients, animals, and laboratory specimens.
We have continued our exploration of the gastrointestinal manifestations of CGD, since almost 50% of patients develop inflammatory bowel disease. We have characterized the gastrointestinal histopathology and the role of surgery in the world's largest cohort of cases. We have characterized the molecular and functional aspects of newly diagnosed cases of Granulibacter bethesdensis, including an isolate from Portugal, which appears to be more pathogenic both in human reports and in CGD mice. We have also defined the microbiomic aspects of CGD bowel disease, which are important in the induction of inflammation.
Identification of the genetic and cellular basis of hyper-IgE recurrent infection syndrome (HIES or Job's syndrome), an autosomal dominant disease characterized by extremely elevated IgE, recurrent sino-pulmonary infections, osteopenia, kyphoscoliosis, pulmonary cysts, and dental abnormalities, as being due to STAT3 has informed broad areas of investigation. With NIAID, NIAMS and extramural collaborators we have identified abnormalities in other cytokines downstream of STAT3, most notably IL-17, which is profoundly low in cells from Job's syndrome patients. Collaborating with investigators in NIAMS we have created a mouse model of STAT3 deficiency which has impaired wound healing and staphylococcal control. Further, the infections in these mice are driven in part by the proinflammatory molecule tumor necrosis factor, offering new avenues for therapy. Collaborating with investigators in NHLBI we continue to study vascular endothelial cells from patients with STAT3 deficeincy in vitro, deriving endothelial and muscle cells from STAT3 deficient patients that have shown impaired chemokine production. With NCI investigators we have developed a comprehensive and successful bone marrow transplantation program for DOCK8 deficiency.
Recently we identified that de novo dominant mutations in the protein RAC2 can cause severe T- and B-cell lymphopenia, myeloid dysfunction, and recurrent respiratory infections. Dominant activating mutations were found in 3 patients.
These combined approaches continue to be productive and help us understand innate immunity and inflammation. These studies will help us understand several different infections, including filamentous fungal infections, at a molecular genetic and functional level.
我们试图通过检查免疫缺陷的后果来了解吞噬细胞在免疫功能中的作用。我们的主要重点是慢性肉芽肿性疾病(CGD),这是由酶NADPH氧化酶缺陷引起的。 NADPH氧化酶参与炎症的产生和控制,免受感染的保护和细胞信号传导。 我们有一个涉及患者,动物和实验室标本的全面投资组合。
我们继续探索CGD的胃肠道表现,因为近50%的患者患有炎症性肠病。我们已经表征了胃肠道组织病理学和手术在世界上最大的病例中的作用。我们已经表征了新诊断的肉芽杆菌贝塞斯丁菌病例的分子和功能方面,其中包括来自葡萄牙的分离株,在人类报告和CGD小鼠中似乎更具致病性。我们还定义了CGD肠道疾病的微生物组方面,这对于诱导炎症很重要。
鉴定超神经复发综合征(HIES或约伯综合征)的遗传和细胞基础,这是一种常染色体显性疾病,其特征是IgE极高,复发性中性肺部感染,骨质减少症,骨s骨,kyphsoscoliosis,knephoscoliosis,knephsoscoliosis,knephsosis,肺部和牙科囊肿和牙齿替代领域,以及已及时的STAT3。使用NIAID,NIAMS和壁外合作者,我们已经确定了STAT3下游的其他细胞因子的异常,最著名的是IL-17,这对Job综合征患者的细胞非常低。与NIAMS的研究人员合作,我们创建了一个STAT3缺乏症的小鼠模型,该模型损害了伤口愈合和葡萄球菌控制。此外,这些小鼠的感染部分是由促炎分子肿瘤坏死因子驱动的,提供了新的治疗途径。与NHLBI的研究人员合作,我们继续研究来自Stat3 Deficeincy体外患者的血管内皮细胞,从STAT3缺陷患者中得出内皮细胞和肌肉细胞,这些患者显示出趋化因子产生受损。在NCI研究人员的情况下,我们为Dock8缺乏症制定了一项全面而成功的骨髓移植计划。
最近,我们确定蛋白质Rac2中的从头显性突变会引起严重的T-和B细胞淋巴细胞减少症,髓样功能障碍和复发性呼吸道感染。在3例患者中发现了主要的激活突变。
这些合并的方法继续提高生产力,并帮助我们了解先天的免疫力和炎症。这些研究将有助于我们了解几种不同的感染,包括分子遗传和功能水平,包括丝状真菌感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven Holland其他文献
Steven Holland的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven Holland', 18)}}的其他基金
Rituximab for Anticytokine Autoantibody-Associated Syndromes
利妥昔单抗治疗抗细胞因子自身抗体相关综合征
- 批准号:
10712564 - 财政年份:
- 资助金额:
$ 158.04万 - 项目类别:
相似国自然基金
臂旁核区域损伤致长时程“昏迷样”动物模型建立及神经机制研究
- 批准号:81901068
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
三江源大型野生食草动物对区域草畜平衡状态影响及管控机制研究
- 批准号:41971276
- 批准年份:2019
- 资助金额:58 万元
- 项目类别:面上项目
基于组蛋白H3K9me3和DNA甲基化修饰协同作用研究早期胚胎发育过程中基因印记区域的调控
- 批准号:31801059
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
使用三代测序技术研究线粒体DNA非编码区域对其DNA复制和转录的调控
- 批准号:31701089
- 批准年份:2017
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
转录因子Msx1与哺乳动物上腭发育的前-后区域化
- 批准号:31771593
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
The epigenetic regulation of inflammation in tissue repair and vascular disease
组织修复和血管疾病中炎症的表观遗传调控
- 批准号:
10582010 - 财政年份:2023
- 资助金额:
$ 158.04万 - 项目类别:
Novel Role of Thrombospondin-1 in Protection against Rupture of Abdominal Aortic Aneurysm
Thrombospondin-1 在预防腹主动脉瘤破裂中的新作用
- 批准号:
10383732 - 财政年份:2021
- 资助金额:
$ 158.04万 - 项目类别:
Inhibiting GPR146 in hypercholesterolemia
抑制高胆固醇血症中的 GPR146
- 批准号:
10255573 - 财政年份:2021
- 资助金额:
$ 158.04万 - 项目类别:
Novel Role of Thrombospondin-1 in Protection against Rupture of Abdominal Aortic Aneurysm
Thrombospondin-1 在预防腹主动脉瘤破裂中的新作用
- 批准号:
10609876 - 财政年份:2021
- 资助金额:
$ 158.04万 - 项目类别:
Improved MRI Detection of Cerebral Microbleeds with Novel Susceptibility Mapping
通过新的磁敏感图改进脑微出血的 MRI 检测
- 批准号:
10056400 - 财政年份:2020
- 资助金额:
$ 158.04万 - 项目类别: